Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,115
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 7,501–7,520 of 17,229 recalls

FDA Recall Terminated Historical recordClass II

L-Carnitine 27 mL Fill in a 30 mL Vial, For Dilution Use Only, 2,025 mg/27 mL (75 mg/mL) Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676396

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Published
October 9, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

L-Carnitine 27 mL in a 30 mL Vial, 4,590 mg/27 mL (170 mg/mL) Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674166

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Published
October 9, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Bimix #3 (Papaverine HCl 30 mg/mL/Phentolamine Mesylate 3 mg/mL) in 5 mL Vial, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676500

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Published
October 9, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Bacteriostatic Water for Injection, 30 mL Vial, Rx Only, KRS Global Biotechnology791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674177

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Published
October 9, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ascorbic Acid (Tapioca Source) 25 g/50 mL (0.5 g/mL) 50 mL Vial--For SC/IM Use-Contains Sulfites, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321675033

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Published
October 9, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ascorbic Acid (Tapioca Source) (PF) 25 g/50 mL (0.5 g/mL) 50 mL Vial-Single Dose Only-For IV/SC/IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487 NDC 3321675412

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Published
October 9, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alpha Lipoic Acid (PF) 750 mg/30 mL (25 mg/mL) 30 mL Single Dose Vial for IV Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674205

by KRS Global Biotechnology, Inc

Reason
Lack of Assurance of Sterility
Published
October 9, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001, NDC 49821-0075-XX

by Johnson Matthey Inc.

Reason
cGMP Deviations: Potential glass contamination
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cisplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001

by Johnson Matthey Inc.

Reason
cGMP Deviations: Potential glass contamination
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001.

by Johnson Matthey Inc.

Reason
cGMP Deviations: Potential glass contamination
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30

by Akorn, Inc.

Reason
cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.

by Cardinal Health dba Specialty Pharmaceutical Services

Reason
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707

by Darmerica, LLC

Reason
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24

by Pfizer Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

ethosuximide capsules, USP, 250 mg, 100-count bottle, Rx Only, Distributed by: Greenstone LLC Peapack, NJ 07977 Made in Netherlands. NDC 59762-2250-2

by Pfizer Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Published
October 2, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count cartons, DISCOUNT drug mart FOOD FAIR, Distributed by: Discount Drug Mart, 211 Commerce Drive, Medina, OH 44256, NDC 53943-021-09.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0097-55.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunswick Pike, Lawrenceville, NJ 08648; NDC 58602-820-09.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648; Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 62011-0315-1); and b) 30-count cartons (NDC 62011-0315-2) HealthMart PHARMACY, Distributed by McKesson, One Post Street, San Francisco, CA 94104.

by Aurolife Pharma, LLC

Reason
Failed Impurities/Degradation Specifications
Published
September 25, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.